David L Mahoney's Net Worth

$134 Million

Estimate Recalculated Jul 3, 2024 04:17PM EST

Who is David L Mahoney?

David L Mahoney has an estimated net worth of $134 Million. This is based on reported shares across multiple companies, which include TERCICA INC, CORCEPT THERAPEUTICS INC, SYMANTEC CORP, and Adamas Pharmaceuticals Inc.

SEC CIK

David L Mahoney's CIK is 0001224091

Past Insider Trading and Trends

2008 was David L Mahoney's most active year for acquiring shares with 8 total transactions. David L Mahoney's most active month to acquire stocks was the month of April. 2012 was David L Mahoney's most active year for disposing of shares, totalling 25 transactions. David L Mahoney's most active month to dispose stocks was the month of October. 2012 saw David L Mahoney paying a total of $959,922.92 for 210,451 shares, this is the most they've acquired in one year. In 2023 David L Mahoney cashed out on 109,467 shares for a total of $825,868.22, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TERCICA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.33K
$9.00
-$29,997.00
0
Oct 16
Form 4
∞
3.33K
—
—
3.33K
May 20
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Oct 13
Form 3
—
0
—
—
0
No matching records found

CORCEPT THERAPEUTICS INC (CORT) Snapshot price: $22.405

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 17
Form 4
+2.24%
27.81K
$12.77
-$17.20
1.27M
Apr 10
Form 4
-1.41%
-17.42K
—
—
1.22M
Aug 29
Form 4
-1.99%
-25.00K
$30.95
-$773,667.50
1.23M
Aug 14
Form 4
—
0
—
—
0
May 19
Form 4
+2.30%
27.8K
$12.75
-$0.72
1.24M
May 8
Form 4
—
0
—
—
0
May 31
Form 4
∞
24.21K
$12.53
-$6.00
24.21K
May 27
Form 4/A
+1.95%
23.52K
$12.43
$2.20
1.23M
May 11
Form 4
—
0
—
—
0
May 26
Form 4
+26.43%
23.52K
$12.43
$2.20
112.5K
May 11
Form 4
—
0
—
—
0
May 27
Form 4
+77.97%
38.98K
$3.47
$135,274.48
88.98K
May 22
Form 4
—
0
—
—
0
Jun 18
Form 4
∞
50K
$0.96
$48,000.00
50K
Jun 3
Form 4
—
0
—
—
0
Aug 20
Form 4
-1.39%
-15.79K
—
—
1.12M
Nov 16
Form 4
—
0
$7.37
-$236,293.14
1.14M
Scheduled
Jul 18 - Jul 19
Form 4/A
—
0
$7.37
-$71,851.61
1.14M
Scheduled
Jul 12 - Jul 13
Form 4
-0.62%
-6.99K
$12.50
-$87,448.23
1.13M
Scheduled
Jul 12 - Jul 13
Form 4
—
0
—
—
0
May 24
Form 4
—
0
$6.03
-$199,500.00
1.17M
Nov 11
Form 4
—
0
—
—
0
Jul 21
Form 4
-2.81%
-33.83K
$5.74
-$194,067.85
1.17M
Jul 8
Form 4
—
0
—
—
0
Jun 18
Form 4
+4.24%
48.95K
$4.05
$198,255.60
1.2M
Mar 27
Form 4
+3.10%
34.66K
$4.31
-$2.49
1.15M
Mar 20
Form 4
+9.81%
100K
$1.85
$185,210.00
1.12M
May 8 - May 9
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
Jun 13
Form 4
+5.04%
48.95K
$2.96
$144,897.92
1.02M
Mar 29
Form 4
-6.48%
-72.48K
—
—
1.05M
Scheduled
Jun 3
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
Jun 23
Form 4
+4.58%
48.95K
$1.66
$81,260.32
1.12M
Apr 21
Form 4
+15.05%
139.86K
$1.38
$193,008.18
1.07M
Oct 16
Form 4
—
0
—
—
0
Jun 11
Form 4
+44.40%
285.71K
$0.69
$196,285.52
929.25K
Feb 6
Form 4
+1.10%
6.99K
$1.45
$10,132.60
643.53K
Nov 11
Form 4
—
0
—
—
0
Jun 10
Form 4
+12.48%
70.61K
$2.77
$195,586.93
636.55K
Mar 25
Form 4
—
0
—
—
0
Dec 19
Form 4
-14.40%
-95.24K
$2.10
-$199,999.80
565.94K
Aug 16
Form 4
+73.88%
200K
$1.00
$200,000.00
470.7K
Mar 30
Form 4
+282.89%
200K
$1.00
$200,000.00
270.7K
Dec 15
Form 4
—
0
—
—
0
Form 4
+39.45%
20K
$5.05
$100,980.00
70.7K
Mar 1
Form 4
+69.00%
20.7K
$5.03
$104,182.87
50.7K
Feb 17 - Feb 21
Form 4
+200.00%
20K
$4.09
$81,892.00
30K
May 31
Form 4
∞
10K
$5.35
$53,461.00
10K
Nov 8
Form 4
—
0
—
—
0
Jul 20
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

SYMANTEC CORP (GEN) Snapshot price: $20.895

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
—
0
—
—
0
Form 4
+588.78%
16.69K
$19.47
$49,998.96
19.53K
May 14
Form 4
+7.16%
12.32K
—
—
184.46K
May 17
Form 4
+5.16%
8.59K
—
—
174.98K
May 15
Form 4
+13.03%
19.18K
$16.94
$49,989.94
166.39K
May 17
Form 4
+6.79%
9.36K
—
—
147.2K
May 19
Form 4
—
0
$23.63
-$40,800.00
137.84K
Scheduled
Dec 15
Form 4
+8.72%
11.06K
—
—
137.84K
May 13
Form 4
+8.24%
9.65K
—
—
126.78K
May 10
Form 4
+17.72%
17.63K
$14.35
-$290,704.08
117.13K
Nov 2
Form 4
+14.43%
12.55K
—
—
99.5K
May 7
Form 4
+13.22%
10.15K
—
—
86.95K
May 16
Form 4
+19.14%
12.34K
—
—
76.8K
May 10
Form 4
+22.29%
11.75K
—
—
64.47K
May 11
Form 4
+29.11%
11.88K
—
—
52.72K
Apr 29 - Apr 30
Form 4
+38.30%
11.31K
—
—
40.83K
May 1 - May 2
Form 4
+44.65%
9.11K
—
—
29.52K
Sep 14
Form 4
+8.26%
1.56K
$16.04
$24,990.32
20.41K
Apr 25
Form 4
—
0
—
—
0
Sep 19
Form 4
+112.97%
10K
$9.91
$99,075.00
18.85K
Aug 26
Form 4
+17.37%
1.31K
$19.07
$24,981.70
8.85K
Apr 25
Form 4
—
0
—
—
0
Sep 17
Form 4/A
+15.67%
511
$48.91
$24,993.01
3.77K
Apr 27
Form 4
—
0
—
—
0
Apr 27
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
No matching records found

Adamas Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-117.78K
—
—
0
Nov 24
Form 4
+4.54%
5K
—
—
115.15K
Jun 2
Form 4
+77.23%
48K
$0.67
$31,920.00
110.15K
Mar 12
Form 4
+8.75%
5K
—
—
62.15K
Jun 3
Form 4
+139.93%
33.33K
$1.76
$58,497.66
57.15K
Sep 17
Form 4
—
0
—
—
0
Sep 11
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Nov 29
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
May 14
Form 4
+147.79%
15.78K
—
—
26.45K
Apr 15
Form 3
—
0
—
—
0
No matching records found